Close Menu

NEW YORK – Berkeley Lights reported on Tuesday a 10 percent decrease in second quarter revenues.

For the three months ended June 30, 2020, the Emeryville, California-based cell analysis firm reported $10.6 million in revenues, down from $11.8 million during the same period last year. Product revenues grew 17 percent to $9.1 million, while service revenue fell 63 percent to $1.5 million.

Milestone and related revenues were $128,000, compared to $3.2 million a year ago.

The firm placed four of its optofluidic platforms in the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.